| 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart … TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ... European heart journal 42 (36), 3599-3726, 2021 | 9360 | 2021 |
| Cardiovascular and renal outcomes with empagliflozin in heart failure M Packer, SD Anker, J Butler, G Filippatos, SJ Pocock, P Carson, ... New England Journal of Medicine 383 (15), 1413-1424, 2020 | 3857 | 2020 |
| Empagliflozin in heart failure with a preserved ejection fraction SD Anker, J Butler, G Filippatos, JP Ferreira, E Bocchi, M Böhm, ... New England Journal of Medicine 385 (16), 1451-1461, 2021 | 2893 | 2021 |
| Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction SD Solomon, JJV McMurray, IS Anand, J Ge, CSP Lam, AP Maggioni, ... New England Journal of Medicine 381 (17), 1609-1620, 2019 | 1819 | 2019 |
| Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991 M Senni, CM Tribouilloy, RJ Rodeheffer, SJ Jacobsen, JM Evans, ... Circulation 98 (21), 2282-2289, 1998 | 1451 | 1998 |
| Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure M Packer, JJV McMurray, AS Desai, J Gong, MP Lefkowitz, AR Rizkala, ... Circulation 131 (1), 54-61, 2015 | 783 | 2015 |
| Congestive heart failure in the community: trends in incidence and survival in a 10-year period M Senni, CM Tribouilloy, RJ Rodeheffer, SJ Jacobsen, JM Evans, ... Archives of internal medicine 159 (1), 29-34, 1999 | 580 | 1999 |
| Developing therapies for heart failure with preserved ejection fraction: current state and future directions J Butler, GC Fonarow, MR Zile, CS Lam, L Roessig, EB Schelbert, ... JACC: Heart Failure 2 (2), 97-112, 2014 | 461 | 2014 |
| PARAGON-HF Investigators and Committees. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction SD Solomon, JJV McMurray, IS Anand, J Ge, CSP Lam, AP Maggioni, ... N Engl J Med 381 (17), 1609-1620, 2019 | 457 | 2019 |
| Sacubitril/valsartan across the spectrum of ejection fraction in heart failure SD Solomon, M Vaduganathan, B L. Claggett, M Packer, M Zile, ... Circulation 141 (5), 352-361, 2020 | 418 | 2020 |
| New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes M Senni, WJ Paulus, A Gavazzi, AG Fraser, J Díez, SD Solomon, ... European heart journal 35 (40), 2797-2815, 2014 | 411 | 2014 |
| Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure A Dei Cas, SS Khan, J Butler, RJ Mentz, RO Bonow, A Avogaro, ... JACC: Heart Failure 3 (2), 136-145, 2015 | 402 | 2015 |
| Heart failure with preserved systolic function: a different natural history? M Senni, MM Redfield Journal of the American College of Cardiology 38 (5), 1277-1282, 2001 | 400 | 2001 |
| Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure K Damman, M Gori, B Claggett, PS Jhund, M Senni, MP Lefkowitz, ... JACC: Heart Failure 6 (6), 489-498, 2018 | 364 | 2018 |
| Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study R Wachter, M Senni, J Belohlavek, E Straburzynska‐Migaj, KK Witte, ... European journal of heart failure 21 (8), 998-1007, 2019 | 358 | 2019 |
| Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: multicenter Lombardy registry E Ammirati, M Cipriani, C Moro, C Raineri, D Pini, P Sormani, ... Circulation 138 (11), 1088-1099, 2018 | 323 | 2018 |
| Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF … G Pulignano, D Del Sindaco, L Tavazzi, D Lucci, M Gorini, F Leggio, ... American heart journal 143 (1), 45-55, 2002 | 301 | 2002 |
| Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial MA Deja, PA Grayburn, B Sun, V Rao, L She, M Krejca, AR Jain, ... Circulation 125 (21), 2639-2648, 2012 | 284 | 2012 |
| Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction WT Abraham, MR Zile, FA Weaver, C Butter, A Ducharme, M Halbach, ... JACC: Heart Failure 3 (6), 487-496, 2015 | 274 | 2015 |
| Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double‐blind, randomized comparison of two uptitration regimens M Senni, JJV McMurray, R Wachter, HF McIntyre, A Reyes, I Majercak, ... European journal of heart failure 18 (9), 1193-1202, 2016 | 273 | 2016 |
